191 related articles for article (PubMed ID: 16380622)
1. Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers.
Ceravolo R; Antonini A; Volterrani D; Rossi C; Goldwurm S; Di Maria E; Kiferle L; Bonuccelli U; Murri L
Neurology; 2005 Dec; 65(12):1971-3. PubMed ID: 16380622
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic evaluation of 8 Polish families with levodopa-responsive parkinsonism.
Krygowska-Wajs A; Kachergus JM; Hulihan MM; Farrer MJ; Searcy JA; Booij J; Berendse HW; Wolters ECh; Wszolek ZK
J Neural Transm (Vienna); 2005 Nov; 112(11):1487-502. PubMed ID: 15785861
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic and postsynaptic nigrostriatal dopaminergic functions in multiple system atrophy.
Hashimoto M; Kawasaki K; Suzuki M; Mitani K; Murayama S; Mishina M; Oda K; Kimura Y; Ishiwata K; Ishii K; Inoue K
Neuroreport; 2008 Jan; 19(2):145-50. PubMed ID: 18185098
[TBL] [Abstract][Full Text] [Related]
4. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson's syndrome.
Kessler KR; Hamscho N; Morales B; Menzel C; Barrero F; Vives F; Gispert S; Auburger G
J Neural Transm (Vienna); 2005 Oct; 112(10):1345-53. PubMed ID: 15785866
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson's disease.
Happe S; Tings T; Koch W; Welsch J; Helmschmied K; Baier PC; Meller J; Wuttke W; Paulus W; Tatsch K; Trenkwalder C
J Neural Transm (Vienna); 2007; 114(5):589-94. PubMed ID: 17187291
[TBL] [Abstract][Full Text] [Related]
7. Nigrostriatal dopamine-independent resting-state functional networks in Parkinson's disease.
Ham JH; Cha J; Lee JJ; Baek GM; Sunwoo MK; Hong JY; Shin NY; Sohn YH; Lee JM; Lee PH
Neuroimage; 2015 Oct; 119():296-304. PubMed ID: 26143204
[TBL] [Abstract][Full Text] [Related]
8. SPECT study of the nigrostriatal dopaminergic system in Huntington's disease.
Hwang WJ; Yao WJ
J Neuroimaging; 2013 Apr; 23(2):192-6. PubMed ID: 22211920
[TBL] [Abstract][Full Text] [Related]
9. Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism.
Kim JY; Kim SY; Kim JM; Kim YK; Yoon KY; Kim JY; Lee BC; Kim JS; Paek SH; Park SS; Kim SE; Jeon BS
Neurology; 2009 Apr; 72(16):1385-9. PubMed ID: 19380697
[TBL] [Abstract][Full Text] [Related]
10. The effect of dopamine on response inhibition in Parkinson's disease relates to age-dependent patterns of nigrostriatal degeneration.
Kübler D; Schroll H; Hamker FH; Joutsa J; Buchert R; Kühn AA
Parkinsonism Relat Disord; 2019 Jun; 63():185-190. PubMed ID: 30765262
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study.
Ceravolo R; Volterrani D; Gambaccini G; Bernardini S; Rossi C; Logi C; Tognoni G; Manca G; Mariani G; Bonuccelli U; Murri L
J Neural Transm (Vienna); 2004 Aug; 111(8):1065-73. PubMed ID: 15254794
[TBL] [Abstract][Full Text] [Related]
12. Pure autonomic failure with altered dopamine transporter imaging.
Compta Y; Martí MJ; Paredes P; Tolosa E
Arch Neurol; 2006 Apr; 63(4):604-5. PubMed ID: 16606777
[No Abstract] [Full Text] [Related]
13. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
14. Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? Against.
Frey KA
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):715-7. PubMed ID: 11976814
[No Abstract] [Full Text] [Related]
15. Quantitative [(123)I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease.
Alvarez-Fischer D; Blessmann G; Trosowski C; Béhé M; Schurrat T; Hartmann A; Behr TM; Oertel WH; Höglinger GU; Höffken H
Neuroimage; 2007 Oct; 38(1):5-12. PubMed ID: 17716921
[TBL] [Abstract][Full Text] [Related]
16. Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C).
Muñoz E; Iranzo A; Rauek S; Lomeña F; Gallego J; Ros D; Santamaría J; Tolosa E
J Neurol; 2011 Dec; 258(12):2248-53. PubMed ID: 21633903
[TBL] [Abstract][Full Text] [Related]
17. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.
Booij J; Bergmans P; Winogrodzka A; Speelman JD; Wolters EC
Synapse; 2001 Feb; 39(2):101-8. PubMed ID: 11180497
[TBL] [Abstract][Full Text] [Related]
18. [Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa].
Cordes M; Poewe W
Nervenarzt; 1994 Oct; 65(10):696-9. PubMed ID: 7808568
[TBL] [Abstract][Full Text] [Related]
19. Nigrostriatal dopamine transporter availability in early Parkinson's disease.
Fazio P; Svenningsson P; Cselényi Z; Halldin C; Farde L; Varrone A
Mov Disord; 2018 Apr; 33(4):592-599. PubMed ID: 29436751
[TBL] [Abstract][Full Text] [Related]
20. Nigrostriatal involvement in ataxia with oculomotor apraxia type 1.
Salvatore E; Varrone A; Criscuolo C; Mancini P; Sansone V; Strisciuglio C; Cicala D; Scarano V; Salvatore M; Pappatà S; De Michele G; Filla A
J Neurol; 2008 Jan; 255(1):45-8. PubMed ID: 18004640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
